Frontlight ResearchEarly access
What researchers published on Follicular lymphoma
3,593 papers, newest first.
Showing 20 of 501
Review[Treatment strategies for lymphoma in older adults].[Rinsho ketsueki] The Japanese journal of clinical hematology
ReviewLow tumor burden follicular lymphoma: The state of the art.HemaSphere
Review[Treatment strategies and future perspectives in follicular lymphoma].[Rinsho ketsueki] The Japanese journal of clinical hematology
ReviewAdvances in CAR-T and CAR-NK Cell Therapy in Follicular Lymphoma: A Review.Transplantation and cellular therapy
Meta-analysisRituximab Versus Watchful Waiting for Asymptomatic Advanced-Stage Low-Tumor-Burden Follicular Lymphoma: A Systematic Review and Meta-Analysis.Clinical lymphoma, myeloma & leukemia
In plain wordsRead moreRead the paper on PubMedReviewFollicular lymphoma and the microenvironment: potential targets and biomarkers.Expert review of clinical immunology
ReviewCanadian Hematology Consensus Group Recommendations for the Management of Relapsed and/or Refractory Follicular Lymphoma.Current oncology (Toronto, Ont.)
Meta-analysisreFLASH: a proof-of-concept meta-analytic framework to validate surrogate endpoints in the absence of randomized clinical trial data.Journal of clinical epidemiology
In plain wordsRead moreRead the paper on PubMedReviewOncogenic Role of BCL6 Rearrangement: A Focus on Follicular and Marginal Zone Lymphomas.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ReviewMosunetuzumab: A bispecific CD20 × CD3 antibody for follicular lymphoma with promising evidence in other B-NHL subtypes.Human vaccines & immunotherapeutics
ReviewFollicular Lymphoma: Novel Therapies and Strategies for Optimal Therapeutic Sequencing.Current oncology reports
Meta-analysisEfficacy and safety of CD19 CAR T-cell therapy in relapsed/refractory follicular lymphoma: A systematic review and meta-analysis.Current research in translational medicine
In plain wordsRead moreRead the paper on PubMedSystematic reviewClinical outcomes of the chemo-free approach in relapsed/refractory follicular lymphoma: A network meta-analysis.British journal of haematology
In plain wordsRead moreRead the paper on PubMedReviewCD20 × CD3 Bispecific Antibodies in B-Cell Non-Hodgkin Lymphomas: Current Evidence, Therapeutic Integration, and Future Directions.Medicina (Kaunas, Lithuania)
ReviewOdronextamab: a bispecific antibody for follicular lymphoma.Expert opinion on investigational drugs
ReviewBeyond Chemoimmunotherapy: Emerging Cellular and Targeted Therapies in Transformed Follicular Lymphoma: A Scoping Review.Cancer control : journal of the Moffitt Cancer Center
ReviewRadiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ReviewSingle-cell analyses redefine cell heterogeneity signatures in diffuse large B-cell lymphoma and follicular lymphoma: Molecular insights and clinical impacts.Journal of the Formosan Medical Association = Taiwan yi zhi
ReviewExtracellular Vesicles in B-Cell Non-Hodgkin Lymphomas: Pathogenesis, Therapeutic Implications, and Biomarker Potential.Biomedicines
Meta-analysisAnti-CD19 chimeric antigen receptor (CAR)-T cell therapy vs. CD20xCD3 bispecific antibody as third- or later-line treatment in follicular lymphoma: a meta-analysis.Annals of hematology
In plain wordsRead moreRead the paper on PubMed